Impact of remission on worries experienced by patients receiving biologic therapy for inflammatory bowel disease

Publikation: Bidrag til tidsskrift/Konferencebidrag i tidsskrift /Bidrag til avisTidsskriftartikelForskningpeer review

DOI

  • Rikke Edelbo, Institut for Klinisk Medicin - Lever-, Mave- og Tarmsygdomme
  • ,
  • Malte Hjerrild, Institut for Klinisk Medicin - Lever-, Mave- og Tarmsygdomme
  • ,
  • Palle Bager

Background: Patients with inflammatory bowel disease (IBD) are more and more often treated with biological therapy, primarily to induce remission and secondarily to maintain remission in IBD. Studies have shown how the patients' health-related quality of life (HRQoL) improves during treatment. However, worry and concern have not improved as rapidly as other HRQoL parameters. Aim: This study aimed to explore the aspects of worry in a population of patients treated with biological therapy. Methods: Patients were asked to score HRQoL on two scales and subsequently asked to elaborate on their worry issues. Findings: The study revealed that worries were independent of disease activity. The main worry issues were lack of energy, emotional impact, sleep, pain, work and body image. Emotional impact and body image were more burdensome for women than men. When elaborating on emotional impact, it was revealed that worries about the future and the burden of IBD were common.

OriginalsprogEngelsk
TidsskriftGastrointestinal Nursing
Vol/bind18
Nummer7
Sider (fra-til)28-33
Antal sider6
ISSN1479-5248
DOI
StatusUdgivet - sep. 2020

Se relationer på Aarhus Universitet Citationsformater

ID: 198719234